Skip to main content

Cramer skeptical of this 'saved-by-Pfizer market' after early positive coronavirus vaccine trial

"I want more information. I frankly don't want to just accept it like this, but the market will," CNBC's Jim Cramer said on Wednesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.